Recently, A3A has been identified as a major source of cytidine deaminase-induced mutations in breast cancer (16–18,57), which has emphasized the importance of understanding what mechanisms influence A3A abundance in cancer cells. Here, APOBEC3A is linked to breast carcinoma.